We use essential cookies (authentication, your saved goals/stack) by default. With your permission we’ll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Exogenous Ketones (BHB salts / ketone esters)
Esters and salts are sold as the same thing but are not remotely equivalent: at a matched dose the ester reaches about 2.8 times the blood ketone level, and half of a typical salt is the L isomer, which does not appear to be oxidised the way the D form is and whose fate is unclear. Both reliably raise ketones — but the flagship endurance claim is null in meta-analysis, and one trial found the ester made high-intensity performance worse.
What the evidence says
Most Exogenous Ketones studies are mechanism or observational rather than RCTs that measure a clinical effect — keep findings provisional.
Most evidence is from high-quality meta-analyses and randomised trials published 1994–2026 with a typical study size of 16 participants.
Based on 135 studies · 9 meta-analyses · 113 RCTs · 2,269 total participants
Confidence
High confidenceBy outcome
Raising blood ketones is essentially certain (pooled effect size 1.50), but the outcome claims are weak: endurance performance is formally null in meta-analysis and one trial found high-intensity performance impaired. The promising cardiac signal rests on two 24-person, two-week trials with surrogate endpoints.
115 rigorous studies
101 randomized trials · 8 meta-analyses · 12 systematic reviews
Our evidence rating for Exogenous Ketones is accountable to this entire body of rigorous research indexed in PubMed — not a hand-picked subset.
PubMed · as of Jul 2026
25 trials ongoing or recruiting · 42 completed on ClinicalTrials.gov
5 of the completed trials have posted results
Registered trials show research momentum for Exogenous Ketones, not proof of effect — a registration is a plan, and posted results are sponsor-reported, not peer-reviewed. They are never counted toward the evidence rating above.
Browse these trials on ClinicalTrials.govClinicalTrials.gov · as of Sep 2026
Exogenous ketones do exactly one thing with certainty: raise blood beta-hydroxybutyrate without carbohydrate restriction. Everything past that is contested, and the ester-versus-salt distinction matters more than any marketing suggests.
In the one head-to-head human pharmacokinetic study, matched doses produced 2.8 mM from the ester versus 1.0 mM from the salt, and the salt was 50% L-BHB — an isomer that is not converted to breath acetone (so it is not being oxidised like the D form) yet is barely excreted either, lingering over 8 hours with an unclear fate.
Because consumer ketone meters read only the D isomer, a labelled 12 g salt is metabolically closer to 6 g. In practice salts reach roughly 0.3-1.0 mM while esters reach 2-4 mM, and salts cannot simply be dosed upward because the BHB arrives bound to sodium, potassium, calcium or magnesium.
On performance — the main reason people buy these — the pooled result across 8 studies and 80 participants is null, and a well-controlled trial found 50 g of ester made 30-minute time-trial power 1.5% WORSE, an impairment that persisted even when bicarbonate neutralised the acidosis.
The genuinely promising direction is cardiac: ketone infusion raised cardiac output by 2.0 L/min in heart failure, and two 2024 Circulation trials replicated haemodynamic benefits with oral ester, though each enrolled only 24 people for two weeks and exercise capacity did not improve.
Cognition shows a modest pooled benefit (SMD 0.29), awkwardly alongside a finding that ketone monoester reduces cerebral blood flow up to 19%. The 'fat burning' claim is refuted outright: 38.7 g/day of salts changed neither total nor sleeping energy expenditure.
D-BHB is taken up and burned, raising TCA-cycle flux. After 25 g of oral ketone ester, myocardial fractional extraction of BHB was 52% in heart failure with reduced ejection fraction versus 39% in controls (p=0.035), and extraction scaled with the degree of cardiac dysfunction and remodelling. Critically, ketone infusion raised myocardial oxygen consumption WITHOUT improving efficiency — this is added fuel, not better fuel economy.
Exogenous ketones lower circulating glucose reliably — glucose fell 0.44 mM after salts and stayed lower through exercise, and pooled across 43 trials the drop is 0.47-0.54 mM. The usual explanation is substrate competition, but it is not settled: in the failing human heart, BHB extraction correlated with lactate extraction and NOT with glucose or fatty-acid extraction, which argues against simple competition at the myocardium.
Raising BHB to 3.3 mM lowered plasma ghrelin, insulin, GLP-1 and PYY, with reported hunger suppressed at 1.5 hours. Note a 24-hour salt study found no appetite change, so this is an acute high-dose ester finding.
BHB inhibits histone deacetylases and is proposed to act via FFAR3, HCAR2 and the NLRP3 inflammasome. These come from narrative reviews and preclinical work and have not been shown to cause any human clinical outcome.
How Exogenous Ketones works — from molecular targets to health outcomes. Click an edge to see supporting research.This visualization is in beta — pathways are being refined and expanded.
Avoid without medical supervision. Be aware this is a precautionary inference — no human trial of exogenous ketones in type 1 diabetes exists, and no case reports of supplement-triggered ketoacidosis were found. Nutritional ketosis (0.5-4 mM) is not ketoacidosis, but insulin deficiency removes the brake on ketone production.
Be cautious with BHB salts and count their sodium, potassium, calcium and magnesium toward your daily total — they are a meaningful mineral load with no established benefit to offset it. The frequently quoted mortality figures (30% rising to 88% on a dose doubling, with hypernatraemia, metabolic alkalosis and kidney-damage markers) come from SEPTIC MICE receiving sodium-BHB by central-catheter parenteral nutrition, and the authors framed their warning as being about critically ill patients. That is not a model of an oral supplement in a healthy person on a low-salt diet, so treat it as a reason for caution about the sodium load rather than as evidence of a specific human hazard.
This is a performance caution rather than a safety one — ketone ester measurably reduced 30-minute time-trial power.
No data whatsoever. Avoid.
These drugs independently raise ketone production and carry a recognised risk of euglycaemic ketoacidosis. Adding an exogenous ketone load is a reasonable caution — though this combination has never been tested in humans, and one heart-failure trial reported benefits in patients already on SGLT2 inhibitors without an adverse signal.
A genuine and generally favourable interaction, but the two headline numbers come from two different trials. In the 30-min time-trial study, co-ingested bicarbonate raised blood D-BHB by 0.9 mM and fully neutralised the ketoacidosis — yet power was still 1.5% lower with the ester. In a separate 3-hour simulated race, 65 g of ester plus bicarbonate raised 15-min time-trial power by 5% versus control (with a 0.5-0.8 mM ketone rise), while ester alone did nothing. So bicarbonate helps in prolonged endurance events but does not rescue a shorter high-intensity effort.
Exogenous ketones lower blood glucose acutely and consistently — monitor if you take glucose-lowering medication.
Relevant to salt forms only, because of their cation load. No interaction study exists; this is inference from the mineral content.
Tip: Mild and self-resolving in trials. High-dose salts are the worst offender; start low and consider taking with food
Tip: Account for the sodium, potassium, calcium and magnesium delivered. Blood electrolytes stayed normal at 12-24 g in healthy adults
Tip: Blood pH fell about 0.10 at rest and bicarbonate fell during exercise. Non-pathological, but it is the likely mechanism behind blunted high-intensity performance
Tip: A dose-dependent trend toward higher resting heart rate was seen in a 10-study meta-analysis, and the cardiac-output rise in healthy volunteers was chronotropy-driven. Unstudied over the long term — relevant if you have arrhythmia, ischaemic heart disease, or are stacking with stimulants
Tip: Dose-dependent, 10-19% reduction with monoester. Clinical significance unknown
Exogenous Ketones has an evidence score of 4/10 — emerging evidence based on 126 indexed studies, including 4 meta-analyses. Esters and salts are sold as the same thing but are not remotely equivalent: at a matched dose the ester reaches about 2.8 times the blood ketone level, and half of a typical salt is the L isomer, which does not appear to be oxidised the way the D form is and whose fate is unclear. Both reliably raise ketones — but the flagship endurance claim is null in meta-analysis, and one trial found the ester made high-intensity performance worse. Representative study: PMID 37327753.
The commonly studied dose of Exogenous Ketones is Ketone ester: 25 g per dose is the standard clinical unit. Salts: no established effective dose — the mineral load caps them below useful ketosis. Individual needs vary — start at the lower end of the range and adjust based on how you respond.
Timing is flexible for Exogenous Ketones — consistent daily use matters more than the time of day. Taken acutely about 30-60 minutes before the demand.
Exogenous Ketones is generally safe at recommended doses, with a few precautions worth noting. The most commonly reported side effects are GI distress (nausea, cramping, reflux), mineral and alkali load from salts, mild transient acidosis from esters. Use caution if any of these apply to you: Type 1 diabetes or insulin-deficient diabetes (precautionary — no human trial exists); Sodium-restricted conditions including hypertension, heart failure and chronic kidney disease, for SALT forms; Pregnancy and breastfeeding (no data at all).
Caffeine
Likely helpsBlocks adenosine receptors to boost alertness, reaction time, and endurance — one of the most proven ergogenic aids.
Alpha-GPC
Likely helpsCrosses the blood-brain barrier to fuel acetylcholine synthesis — supports focus, memory, and power output in athletes.
Theacrine
Mostly mechanism / observationalCaffeine-like purine alkaloid from kucha tea. Small RCTs suggest subjective energy and mood benefits and good safety, but objective performance gains are inconsistent.
CoQ10
Likely helpsA lipid-soluble antioxidant central to mitochondrial energy production, with the strongest trial support for fertility/IVF outcomes and heart failure.
Explore: Best supplements for Focus, Memory & MoodBest supplements for Athletic PerformanceBest supplements for Vitality & Longevity
Reviewed by Dr. Baher Al Hakim · Last reviewed July 2026 · evidence from 135 studies · how we score · editorial policy
This information is for educational purposes only. It is not a substitute for professional medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any supplement or medication.
Tap node to isolate • Pinch to zoom • Tap edge for research